TAIPEI, July 19 (Reuters) - Taiwan's government on Monday
approved the production of Medigen Vaccine Biologics Corp's
COVID-19 vaccine candidate.
The health ministry said in clinical trials in Taiwan the
antibodies created by Medigen's vaccine candidate have been
proven to be "no worse than" those created by AstraZeneca PLC
vaccines, and that there were no major safety concerns.
(Reporting by Ben Blanchard and Yimou Lee; Editing by